We serve Chemical Name:Ethyl 2-(3-chlorobenzyl)-3-oxobutanoate CAS:30292-75-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Ethyl 2-(3-chlorobenzyl)-3-oxobutanoate
CAS.NO:30292-75-2
Synonyms:Oxamidsaeure-N-essigsaeure-diaethylester;N-Ethoxycarbonylmethyl-oxalamic acid ethyl ester;N-Aethoxyoxalyl-glycin-aethylester;ethyl N-ethoxalylglycinate;N-ethoxyoxalyl-glycine ethyl ester
Molecular Formula:C13H15ClO3
Molecular Weight:254.70900
HS Code:2918300090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:43.37000
Exact Mass:254.07100
LogP:2.65080
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Oxamidsaeure-N-essigsaeure-diaethylester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-ethoxyoxalyl-glycine ethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Oxamidsaeure-N-essigsaeure-diaethylester Use and application,N-Aethoxyoxalyl-glycin-aethylester technical grade,usp/ep/jp grade.
Related News: The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said. Ethyl 2-(3-chlorobenzyl)-3-oxobutanoate manufacturer With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout. Ethyl 2-(3-chlorobenzyl)-3-oxobutanoate supplier The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said. Ethyl 2-(3-chlorobenzyl)-3-oxobutanoate vendor With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout. Ethyl 2-(3-chlorobenzyl)-3-oxobutanoate factory The third-to-market BTK inhibitor is also looking to report top-line results from a front-line trial later this year. Imbruvica could feel more pressure if that study also turns out successful.
